Haemonetics
HAE
#3904
Rank
$3.46 B
Marketcap
$76.19
Share price
1.59%
Change (1 day)
0.89%
Change (1 year)

Haemonetics (HAE) - P/B ratio

P/B ratio as of July 2026 : 4.34

According to Haemonetics's latest financial reports the company has a price-to-book ratio of 2.62415.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Haemonetics - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-314.23-1.59%
2024-12-314.30-6.6%
2023-12-314.60-10.33%
2022-12-315.1338.29%
2021-12-313.71-55.76%
2020-12-318.38-16.79%
2019-12-3110.127.03%
2018-12-317.93112.77%
2017-12-313.7338.4%
2016-12-312.6918.35%
2015-12-312.28-1.49%
2014-12-312.31-12.78%
2013-12-312.65-2.13%
2012-12-312.7124.81%
2011-12-312.17-10.05%
2010-12-312.41-0.28%
2009-12-312.42-13.21%
2008-12-312.79-18.27%
2007-12-313.4129.93%
2006-12-312.62-15.43%
2005-12-313.1011.18%
2004-12-312.7923.95%
2003-12-312.25-4.25%
2002-12-312.35

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.61 75.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
2.18-49.88%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
3.75-13.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
1.95-55.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
1.74-59.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
5.52 26.98%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
1.80-58.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus Corporation
CERS
10.0 130.97%๐Ÿ‡บ๐Ÿ‡ธ USA